Pulmonary flow reserve in children with idiopathic pulmonary arterial hypertension: Implications for diagnosis and therapy

European Journal of Medical Research

Volumn 11, Issue 5, 2006, Pages 208-213

  Zimmermann, R ^a   Kreuder, J ^a   Michel Behnke, I ^a   Voelkel, N F ^b   Schranz, D ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Acetylcholine; Children; Endothelium; Pulmonary hypertension

Indexed keywords

ACETYLCHOLINE; ILOPROST; OXYGEN; PROSTACYCLIN; SILDENAFIL;

ANGIOGRAPHY; ARTICLE; BLOOD VESSEL REACTIVITY; CELL FUNCTION; CLINICAL ARTICLE; DOPPLER FLOWMETER; ENDOTHELIUM CELL; HUMAN; LUNG BLOOD FLOW; LUNG PRESSURE; MORTALITY; PULMONARY ARTERY; PULMONARY HYPERTENSION; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE;

ACETYLCHOLINE; ADOLESCENT; BLOOD PRESSURE; CHILD; CHILD, PRESCHOOL; ENDOTHELIAL CELLS; EPOPROSTENOL; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION, PULMONARY; ILOPROST; INFANT; LUNG; PIPERAZINES; REGIONAL BLOOD FLOW; VASODILATOR AGENTS;

EID: 33646722663     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Voelkel NF, Tuder RM, Weir EK. Pathophysiology of primary pulmonary hypertension. In: Rubin L, Rich S, eds. Primary pulmonary hypertension. New York: Marcel Dekker, 1997:83-129.
2. Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary hypertension. N Engl J Med. 2004 30: 351 (14): 1425-36
3. Giaid A, Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med. 1995;333:214-221.
4. Geraci MW, Gao B, Shepherd DC, Moore MD, Westcott JY, Fagan KA, Alger LA, Tuder RM, Voelkel NF. Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension. J Clin Invest. 1999;103:1509-1515.
5. Wedgwood S, Black SM. Endothelin-1 decreases endothelial NOS expression and activity through ETA receptor mediated generation of hydrogen peroxide. Am J Physiol Lung Cell Mol Physiol. 2004 Nov 5; Epub ahead of print.
6. Yung D, Widlitz AC, Rosenzweig EB, Kerstein D, Maislin G, Barst RJ. Outcomes in children with idiopathic pulmonary arterial hypertension. Circulation. 2004;110:660-665
7. Sitbon O, Humbert M, Nunes H, Parent F, Garcia G, Herve P, Rainisio M, Simonneau G. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol. 2002; 40:780-
8. Rosenzweig E, Widlitz A, Barst R. Pulmonary Arterial Hypertension in Children. Pediatr Pulmonol. 2004; 38:2-22
9. Celermajer DS, Cullen S, Deanfield JE. In vivo detection of endothelium dependent and independent pulmonary artery relaxation in children. Br Heart J. 1993; 69:298-302
10. Cooper CJ, Landzberg MJ, Anderson TJ, et al. Role of nitric oxide in the local regulation of pulmonary vascular resistance in humans. Circulation. 1996; 93:266-271
11. Ludmer PL, Selwyn AP, Shook TL, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med. 1986; 315:1046-1051
12. Dinh-Xuan AT, Higenbottam TW, Pepke-Zaba J et al. Aceylcholine and adenosine diphosphate cause endothelium-dependent relaxation of isolated human pulmonary arteries. Eur Respir J. 1990; 3:633-638
13. Feddersen CO, McMurty IF, Henson P, Voelkel NF. Acetylcholine induces vasodilation and prostacyclin synthesis in rat lungs. Prostaglandins. 1986; 31(5):973-987
14. Celermajer DS, Cullen S, Deanfield JE. Impairment of endothelium-dependent pulmonary artery relaxation in children with congenital heart disease and abnormal pulmonary hemodynamics. Circulation. 1993; 87:440-447
15. Celemajer DS, Dollery C, Burch M, Deanfield JE. Role of Endothelium in the maintenance of low pulmonary vascular tone in normal children. Circulation. 1994;89:2041-2044
16. Borges AC, Wensel R, Opitz C, et al. Relationship between hemodynamics and morphology in pulmonary hypertension. A quantitative intravascular ultrasound study. Eur Heart J. 1997; 18:1988-94
17. Vapaatalo H, Mervaala E. Clinically important factors influencing endothelial function. Med Sci Monit. 2001; 7(5): 1075-1085
18. Xue C, Johns RA. Endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med. 1995;333:1642-1644
19. Cooke JP. A novel mechanism for pulmonary arterial hypertension? Circulation. 2003; 108:1420-1426
20. Asreuy J, Cunha FQ, Liew FY, Moncada S. Feedback inhibition of nitric oxide synthase activity by nitric oxide. Br J Pharmacol. 1993; 108:833-37
21. Zimmermann R, Kreuder J, Michel-Behnke I, Hagel K-J, Schranz D. Endothelium-dependent pulmonary artery relaxation in children with idiopathic pulmonary hypertension. Cardiol Young. 2004; 14(Suppl 2):3
22. Zimmermann R, Kreuder J, Hagel K-J, Michel-Behnke I, Hübner P, Thul J, Schranz D. Endothel-abhängige Fluss-reserve, Endothel-unabhängige Vasodilatation and biochemische Marker des NO-Stoffwechsels zur Beurteilung des pulmonalen Gefäßsystems bei Kindern mit Pulmonaler Hypertonie. Z Kardiol. 2002; 91 (Suppl)1:210